论文部分内容阅读
将2009年~2013年住院的2250例糖尿病患者按入院先后次序随机分为2组,即持续皮下输注胰岛素组(CSII)及多次皮下注射胰岛素组(MSII)。2 250例糖尿病患者血糖均较入院时明显下降(P<0.05),但下降程度及血糖达标时间两组相比,有统计学差异(P>0.05)。持续胰岛素泵皮下注射胰岛素降血糖治疗可有效降低血糖,减少住院日,节约卫生成本,减少并发症的发生,低血糖发生率亦低于单次注射者,临床使用安全有效。
2250 diabetic patients hospitalized from 2009 to 2013 were randomly divided into two groups according to hospital admission order: continuous subcutaneous infusion of insulin group (CSII) and multiple subcutaneous injection of insulin group (MSII). The blood glucose in 2 250 diabetic patients was significantly lower than that at admission (P <0.05), but there was a significant difference between the two groups in the degree of decline and the standard of blood glucose (P> 0.05). Continuous insulin pump hypodermic insulin hypoglycemic treatment can effectively reduce blood sugar, reduce hospitalization days, save health costs and reduce complications, the incidence of hypoglycemia is also lower than a single injection, the safe and effective clinical use.